-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] In the context of the continuous development of the pharmaceutical industry, China's pharmaceutical equipment market has begun to usher in good development opportuniti.
But at the same time, as the market concentration continues to increase, the competition becomes more inten.
It is understood that under the circumstance that equipment requirements and standards are getting higher and higher, and the product overlap rate is high, pharmaceutical equipment companies have begun to seek breakthroughs and upgrades in products and processes, and are further expanding product lines and expanding new marke.
Pharmaceutical equipment companies are further expanding their product lines (Source: Pharmaceutical Network) For example, recently, Truking Technology disclosed a plan for additional asset purchases, and plans to purchase its holding subsidiary, Truking Feiyun Pharmaceutical Equipment (Changsha) .
, L.
( A total of 49% of the shares held by minority shareholders of "Chutian Yunfei.
It is reported that Chutian Yunfei currently has a total of 70 patent applications, including nearly 10 invention paten.
The company's patent layout mainly focuses on filling machines, hard capsules and other related fiel.
After the transaction is completed, Truking Feiyun will become a wholly-owned subsidiary of the listed compa.
Truking Technology stated that after the completion of this transaction, it will enhance its control over Truking Feiyun, which will facilitate the company to implement its layout in the field of solid preparation production solutions, and help the company to expand its product ran.
At the same time, it will also enhance profitability, give play to synergies, optimize the overall business layout of listed companies, and enhance the anti-risk capabilities of listed companies, in line with the strategic development needs of Truking Technology's "one vertical, one horizontal and one platfor.
It is understood that in recent years, Chutian Technology has been actively implementing the development strategy of "one vertical, one horizontal and one platform", deepening the layout of biopharmaceutical equipment, strengthening synergy among subsidiaries, and improving internal operation and management capabiliti.
For example, as early as 2015, in order to realize the development strategy of "one vertical, one horizontal and one platform" for medical equipment, as soon as possible from the past to sell simple products or linkage lines to provide overall solutions for medical equipment and build a medical smart factory development, we will cooperate with All shareholders of Sichuan Pharmaceutical Design Institute .
, L.
(including 27 shareholders including Wang Xuejin) signed the Equity Transfer Agreement, and acquired the target company with its own funds of 398 million yu.
After the acquisition, Chutian Technology held its 100 % of the equi.
At present, in addition to Chutian Technology expanding its product line, Canaan Technology has also invested in the establishment of a pharmaceutical equipment company recent.
Tianjin Canan Pharmaceutical Equipment .
, L.
has a registered capital of 10 million yuan, and its business scope includes: manufacturing of special pharmaceutical equipment, manufacturing of pumps and vacuum equipment, manufacturing of industrial automatic control systems, and research and development of biochemical produc.
Qichacha’s equity penetration shows that the company is jointly held by Canaan Technology’s wholly-owned subsidiary Canaan (Tianjin) Technology .
, L.
and Wenzhou Yilin Enterprise Management Partnership (Limited Partnershi.
From the above point of view, expanding the product line of pharmaceutical equipment is gradually becoming an important operation for leading pharmaceutical equipment companies to seize the pharmaceutical market, but it is not enough to simply expand the product li.
Industry insiders said that while pharmaceutical equipment companies are expanding their products, they should also actively promote product technology upgrades, master and continuously improve high-end pharmaceutical technologies, in order to stand out in the market and achieve long-term developme.
If expanding the product line of pharmaceutical equipment is the foundation, then actively promoting the upgrading of product technology is a key step for pharmaceutical equipment companies to seize the huge market of the pharmaceutical indust.
The analysis believes that through continuous innovation and upgrading, the pharmaceutical industry can continue to solve various difficult problems for enterprises, provide more effective solutions for industrial development, and even improve its own market competitivene.
Disclaimer: Under no circumstances shall the information or opinions expressed in this article constitute investment advice to anyone
But at the same time, as the market concentration continues to increase, the competition becomes more inten.
It is understood that under the circumstance that equipment requirements and standards are getting higher and higher, and the product overlap rate is high, pharmaceutical equipment companies have begun to seek breakthroughs and upgrades in products and processes, and are further expanding product lines and expanding new marke.
Pharmaceutical equipment companies are further expanding their product lines (Source: Pharmaceutical Network) For example, recently, Truking Technology disclosed a plan for additional asset purchases, and plans to purchase its holding subsidiary, Truking Feiyun Pharmaceutical Equipment (Changsha) .
, L.
( A total of 49% of the shares held by minority shareholders of "Chutian Yunfei.
It is reported that Chutian Yunfei currently has a total of 70 patent applications, including nearly 10 invention paten.
The company's patent layout mainly focuses on filling machines, hard capsules and other related fiel.
After the transaction is completed, Truking Feiyun will become a wholly-owned subsidiary of the listed compa.
Truking Technology stated that after the completion of this transaction, it will enhance its control over Truking Feiyun, which will facilitate the company to implement its layout in the field of solid preparation production solutions, and help the company to expand its product ran.
At the same time, it will also enhance profitability, give play to synergies, optimize the overall business layout of listed companies, and enhance the anti-risk capabilities of listed companies, in line with the strategic development needs of Truking Technology's "one vertical, one horizontal and one platfor.
It is understood that in recent years, Chutian Technology has been actively implementing the development strategy of "one vertical, one horizontal and one platform", deepening the layout of biopharmaceutical equipment, strengthening synergy among subsidiaries, and improving internal operation and management capabiliti.
For example, as early as 2015, in order to realize the development strategy of "one vertical, one horizontal and one platform" for medical equipment, as soon as possible from the past to sell simple products or linkage lines to provide overall solutions for medical equipment and build a medical smart factory development, we will cooperate with All shareholders of Sichuan Pharmaceutical Design Institute .
, L.
(including 27 shareholders including Wang Xuejin) signed the Equity Transfer Agreement, and acquired the target company with its own funds of 398 million yu.
After the acquisition, Chutian Technology held its 100 % of the equi.
At present, in addition to Chutian Technology expanding its product line, Canaan Technology has also invested in the establishment of a pharmaceutical equipment company recent.
Tianjin Canan Pharmaceutical Equipment .
, L.
has a registered capital of 10 million yuan, and its business scope includes: manufacturing of special pharmaceutical equipment, manufacturing of pumps and vacuum equipment, manufacturing of industrial automatic control systems, and research and development of biochemical produc.
Qichacha’s equity penetration shows that the company is jointly held by Canaan Technology’s wholly-owned subsidiary Canaan (Tianjin) Technology .
, L.
and Wenzhou Yilin Enterprise Management Partnership (Limited Partnershi.
From the above point of view, expanding the product line of pharmaceutical equipment is gradually becoming an important operation for leading pharmaceutical equipment companies to seize the pharmaceutical market, but it is not enough to simply expand the product li.
Industry insiders said that while pharmaceutical equipment companies are expanding their products, they should also actively promote product technology upgrades, master and continuously improve high-end pharmaceutical technologies, in order to stand out in the market and achieve long-term developme.
If expanding the product line of pharmaceutical equipment is the foundation, then actively promoting the upgrading of product technology is a key step for pharmaceutical equipment companies to seize the huge market of the pharmaceutical indust.
The analysis believes that through continuous innovation and upgrading, the pharmaceutical industry can continue to solve various difficult problems for enterprises, provide more effective solutions for industrial development, and even improve its own market competitivene.
Disclaimer: Under no circumstances shall the information or opinions expressed in this article constitute investment advice to anyone
